Anthony Sferruzza
Impact in
- Gastroenterology top 2%
- Celiac Disease Research and Management
- Epidemiology top 10%
- Microscopic Colitis
- Liver Disease Diagnosis and Treatment
Papers in
- Co-authors
- Craig Sturgeon (1 shared paper)Carlo Catassi (1 shared paper)Sandra Clipp (1 shared paper)Daniel Gelfond (1 shared paper)Bushra Bhatti (1 shared paper)Debby Kryszak (1 shared paper)Elaine Leonard Puppa (1 shared paper)Alessio Fasano (1 shared paper)
- Journals
- Journal of Clinical Oncology (6 papers)Blood (3 papers)Anti-Cancer Drugs (2 papers)Cancer (1 paper)Clinical Chemistry (1 paper)
- Partner nations
- United StatesItaly
In The Last Decade
Anthony Sferruzza
20 papers receiving 604 citations
Peers
Comparison fields: 5 of 58
- Gastroenterology 262
- Epidemiology 251
- Oncology 188
- Hepatology 54
- Immunology 123
Countries citing papers authored by Anthony Sferruzza
This map shows the geographic impact of Anthony Sferruzza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Sferruzza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Sferruzza more than expected).
Fields of papers citing papers by Anthony Sferruzza
This network shows the impact of papers produced by Anthony Sferruzza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Sferruzza. The network helps show where Anthony Sferruzza may publish in the future.
Co-authors
The 25 scholars most cited alongside Anthony Sferruzza, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 276 | |
| 2 | 1991 | 85 | |
| 3 | 2009 | 54 | |
| 4 | 2007 | 51 | |
| 5 | 2013 | 47 | |
| 6 | 1989 | 25 | |
| 7 | 2002 | 21 | |
| 8 | 2011 | 17 | |
| 9 | 1982 | 15 | |
| 10 | Continuous infusion interleukin-2 and tumor-derived activated cells as treatment of advanced solid tumors: a National Biotherapy Study Group Trial. | 1991 | 13 |
| 11 | 2009 | 10 | |
| 12 | 2006 | 10 | |
| 13 | 2009 | 3 | |
| 14 | 2007 | 3 | |
| 15 | 2003 | 2 | |
| 16 | 2016 | 1 | |
| 17 | 2012 | 1 | |
| 18 | 2007 | 1 | |
| 19 | 2009 | 1 | |
| 20 | 2006 | 1 |
About Anthony Sferruzza
Anthony Sferruzza is a scholar working on Oncology, Surgery, Hematology, Molecular Biology and Cancer Research, having authored 21 papers that have together received 637 indexed citations. Recurring topics across this work include CAR-T cell therapy research (3 papers), Platelet Disorders and Treatments (3 papers), Heparin-Induced Thrombocytopenia and Thrombosis (3 papers), Hepatocellular Carcinoma Treatment and Prognosis (2 papers), Computational Drug Discovery Methods (2 papers), Melanoma and MAPK Pathways (2 papers), Cancer Research and Treatments (2 papers) and Cancer, Lipids, and Metabolism (2 papers). The work is most often cited by research in Gastroenterology (262 citations), Epidemiology (251 citations), Oncology (188 citations), Hepatology (54 citations) and Immunology (123 citations). Anthony Sferruzza has collaborated with scholars based in United States and Italy. Frequent co-authors include Craig Sturgeon, Carlo Catassi, Sandra Clipp, Daniel Gelfond, Bushra Bhatti, Debby Kryszak, Elaine Leonard Puppa, Alessio Fasano, Kathy J. Helzlsouer and Richard A. Bender. Their work appears in journals such as Journal of Clinical Oncology, Blood, Anti-Cancer Drugs, Cancer and Clinical Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.